Zhejiang Xianju Pharmaceutical Co Ltd 2022 SR
The report highlights Xianju Pharma's 50th anniversary and its performance in 2022, achieving record operating income and profits. It details the company's focus on steroid hormone drugs and its commitment to ESG through improved corporate governance, green production, and employee care. Key achievements include passing several international quality inspections and receiving an "A" rating for information disclosure from the Shenzhen Stock Exchange. The company also emphasized innovation, investing over 6% of sales revenue into R&D and advancing its product pipelines in gynecology and anesthesia.
Company: Zhejiang Xianju Pharmaceutical Co Ltd
Sector: Health Care
Country: China
Year: 2022
Type: SR
Pages: 45
Zhejiang Xianju Pharmaceutical Co Ltd
Corporate Social Responsibility Report
The report highlights Xianju Pharma's 50th anniversary and its performance in 2022, achieving record operating income and profits. It details the company's focus on steroid hormone drugs and its commitment to ESG through improved corporate governance, green production, and employee care. Key achievements include passing several international quality inspections and receiving an "A" rating for information disclosure from the Shenzhen Stock Exchange. The company also emphasized innovation, investing over 6% of sales revenue into R&D and advancing its product pipelines in gynecology and anesthesia.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Women on Board
Women in Management
Employees